Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

What's new

DPUK position on coronavirus

New webpage featuring information and guidance

Ulster datathon cancelled

We are monitoring the COVID19 situation and it is with regret that we have decided to postpone the Ulster datathon.

Wales leads the way in dementia research

Health records from over 80% of the Welsh population have been used to create the UK’s first national-scale health database for dementia research. DPUK researchers have used Welsh NHS records to create the new resource, allowing doctors and scientists to investigate fundamental questions about dementia with greater confidence, paving the way for new treatments.

New brain scan may pinpoint early progression of Alzheimer’s disease

The New therapeutics in Alzheimer's Disease (NTAD) study, supported by Dementias Platform UK (DPUK), is testing new brain scans that are revealing early changes in the brain that are a signature of Alzheimer’s disease. These markers for the disease will be used to test whether experimental treatments can delay, or even prevent, the progression of the disease.

Dates for your diary

Cognitive Aging Conference

Thursday, 16 April 2020 to Sunday, 19 April 2020

Dr Sarah Bauermeister will be presenting at the Cognitive Aging Conference. This is the premier conference for presentation of research about aging and cognition based on experimental cognitive psychology, cognitive neuroscience of aging, human factors and ergonomics, and longitudinal studies of age-related cognitive change, its correlates, and determinants.

Longitudinal studies

Monday, 20 April 2020 to Wednesday, 22 April 2020

This conference at the Wellcome Genome Campus will bring together scientists working on studies in childhood, adult and late life to identify novel biomarkers of functional decline and development of disease susceptibility, and to understand the lifetime drivers and underlying pathways of these processes.

Funding call: fluid biomarkers

Thursday, 23 April 2020

This funding call from the Weston Brain Institute provides seed funding, without requirement for preliminary data, to support high-risk, high-reward, translational research on novel biomarkers detected in patient-derived fluids for neurodegenerative diseases of ageing.